ANI Pharmaceuticals Q4 2025: Strong Growth, But Execution Risks Emerge [Seeking Alpha]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Seeking Alpha
I see near-term risks from seasonally weaker Cortrophin sales due to insurance reverifications and delayed impact from the expanded gout sales force. Management reaffirmed 2026 guidance for $1.06-$1.12B revenue and up to $290M adjusted EBITDA, but execution and timing risks remain. ANIP trades at a steep valuation discount (8.2x forward P/E) despite a double-digit EPS growth outlook; I downgrade to Hold given execution uncertainties. Svetlana Borisova/iStock via Getty Images Thesis ANI Pharmaceuticals, Inc. ( ANIP ) has just reported a 4Q25 non-GAAP EPS of $2.33, a figure that beat consensus by about $0.35. Revenue came in at $247.1 million, rising 30% year-over-year and also exceeding expectations by about $16.07 million. The company This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article mysel
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals Inc (ANIP) Q4 2025 Earnings Call Highlights: Record Revenue and Strong ... [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals, Inc. (ANIP) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- ANI Pharma (ANIP) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals (NASDAQ:ANIP) Beats Expectations in Strong Q4 CY2025, Stock Jumps 12.4% [Yahoo! Finance]Yahoo! Finance
ANIP
Earnings
- 2/27/26 - Beat
ANIP
Sec Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- 3/3/26 - Form 4
- ANIP's page on the SEC website